lentinan has been researched along with Cancer of Lung in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Cheng, M; Dong, P; Du, X; Li, M; Yuan, Z | 1 |
| He, Y; Liu, G; Qi, Z; Qin, S; Xu, H; Xue, J; Zhao, Q; Zhu, J | 1 |
| Jia, Y; Kong, X; Li, X; Liang, F; Liu, H; Pang, W; Wu, T; Yan, H; Zhao, C; Zhao, L | 1 |
| Liu, Y; Qi, H; Wang, N; Xiao, C | 1 |
| Chang, Y; Guo, Z; Hao, C; He, Y; Jiang, Y; Li, X; Liu, Y; Luo, H; Wang, H; Zeng, P; Zhang, G; Zhang, L; Zhang, M; Zhang, Y | 1 |
| Deng, S; Fan, P; Huang, Y; Kuai, J; Liu, X; Wang, X; Wu, Q; Yang, D; Zhang, G; Zheng, X; Zhou, P | 1 |
| Chen, M; Ma, LJ; Peng, M; Wang, XE; Wang, YH; Xie, GM; Zhang, J; Zhou, Q | 1 |
| Li, L; Wang, H; Yin, X; Ying, J; Zhang, H | 1 |
| Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T | 1 |
| Chen, L; Jia, YJ; Li, XJ | 1 |
| Fukushima, M; Mushiake, H; Nukatsuka, M; Shimao, K; Tahara, H; Tsunoda, T | 1 |
| Bradner, WT; Reed, FC; Rose, WC; Siminoff, P | 1 |
| Hamuro, J; Kikuchi, T; Suga, T; Suzuki, M; Takatsuki, F | 1 |
| Abe, S; Kimura, S; Mizuno, DI; Ohnishi, M; Oshima, H; Yamaguchi, H; Yamazaki, M | 1 |
| Ladányi, A; Lapis, K; Tímár, J | 1 |
| Kosaka, A; Sakaguchi, T; Watahiki, Y | 1 |
| Ogura, T; Sone, S; Yamasaki, K; Yamashita, T | 1 |
| Hamada, J; Hosokawa, M; Kobayashi, H; Komatsumoto, M; Li, S; Okayasu, T; Takeichi, N; Tanabe, T | 1 |
| Hayashibara, H; Moriyuki, H; Niitsu, I; Ohishi, K; Shiio, T; Tsuchiya, Y; Yoshihama, T | 1 |
| Kitamura, K; Ohishi, K; Shiio, T; Yugari, Y | 1 |
| Abe, S; Mizuno, D; Takahashi, K; Yamazaki, M | 1 |
| Abe, S; Gatanaga, T; Mizuno, D; Takahashi, K; Yamazaki, M | 1 |
| Chihara, G | 1 |
3 review(s) available for lentinan and Cancer of Lung
| Article | Year |
|---|---|
Lentinan combined with cisplatin for the treatment of non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drugs, Chinese Herbal; Humans; Lentinan; Lung Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.
Topics: Adjuvants, Immunologic; Asian People; China; Humans; Lentinan; Lung; Lung Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Humans; Lentinan; Lung Neoplasms; Prospective Studies; Treatment Outcome | 2015 |
1 trial(s) available for lentinan and Cancer of Lung
| Article | Year |
|---|---|
[Clinical observation of thermotherapy combined with thoracic injection of lentinan in treatment of cancerous hydrothorax of patients with lung cancer].
Topics: Adult; Aged; Biological Products; Combined Modality Therapy; Female; Humans; Hydrothorax; Hyperthermia, Induced; Injections; Lentinan; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged | 2011 |
19 other study(ies) available for lentinan and Cancer of Lung
| Article | Year |
|---|---|
Lentinan triggers oxidative stress-mediated anti-inflammatory responses in lung cancer cells.
Topics: A549 Cells; Anti-Inflammatory Agents; Humans; Inflammation; Lentinan; Lung Neoplasms; Neoplasm Proteins; Oxidative Stress | 2022 |
Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils.
Topics: Breast Neoplasms; CD8-Positive T-Lymphocytes; Female; Humans; Lentinan; Lung Neoplasms; Neutrophils | 2022 |
Lentinan Attenuated the PM2.5 Exposure-Induced Inflammatory Response, Epithelial-Mesenchymal Transition and Migration by Inhibiting the PVT1/miR-199a-5p/caveolin1 Pathway in Lung Cancer.
Topics: Base Sequence; Caveolin 1; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-6; Lentinan; Lung Neoplasms; MicroRNAs; Particulate Matter; RNA, Long Noncoding; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Colorectal Neoplasms; Female; Interferon-gamma; Lentinan; Lung Neoplasms; Mice; Mice, Nude; T-Lymphocytes; Xenograft Model Antitumor Assays | 2018 |
Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytokines; Female; Humans; Immunomodulation; Immunotherapy; Lentinan; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; T-Lymphocyte Subsets; Vinorelbine | 2020 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Lentinan; Lung Neoplasms; Lymphatic Metastasis; Oxonic Acid; Recurrence; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed | 2008 |
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Drug Combinations; Fibrosarcoma; Immunotherapy, Adoptive; Lentinan; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Oxonic Acid; Pyridines; Rats; Rats, Inbred Strains; Spleen; Survival Rate; T-Lymphocytes, Cytotoxic; Tegafur | 2005 |
Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.
Topics: Animals; Cell Line; Combined Modality Therapy; Female; Immunotherapy; Lentinan; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Polysaccharides | 1984 |
Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatments.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fibrosarcoma; Hypersensitivity, Delayed; Immunologic Memory; Immunotherapy; Interleukin-2; Killer Cells, Natural; Lentinan; Lung Neoplasms; Melanoma, Experimental; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Postoperative Care; Preoperative Care | 1994 |
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
Topics: Animals; Antineoplastic Agents; Body Weight; Bordetella pertussis; Cell Line; Cyclophosphamide; Drug Screening Assays, Antitumor; Escherichia coli; Fibrosarcoma; Gram-Negative Bacteria; Lentinan; Lethal Dose 50; Lipopolysaccharides; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred ICR; Neoplasms, Experimental; Tumor Cells, Cultured | 1994 |
Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.
Topics: Animals; Cytotoxicity, Immunologic; Humans; Lentinan; Lung Neoplasms; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms | 1993 |
[A case of breast cancer with thrombosis during treatment of lung metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intravenous; Lentinan; Lung Neoplasms; Medroxyprogesterone Acetate; Pulmonary Embolism; Radiography; Tamoxifen; Tegafur; Thrombophlebitis; Uracil | 1993 |
Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cytotoxicity, Immunologic; Drug Synergism; Interleukin-2; Killer Cells, Natural; Lentinan; Lung Neoplasms; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Spleen | 1989 |
[Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Fluorouracil; Lentinan; Lung Neoplasms; Mammary Neoplasms, Experimental; Rats; Rats, Inbred SHR; Tegafur; Uracil | 1988 |
[Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Topics: Animals; Combined Modality Therapy; Female; Lentinan; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Polysaccharides; Radiotherapy Dosage | 1988 |
[Suppressive effect of lentinan on pulmonary metastases in murine tumors].
Topics: Animals; Fibrosarcoma; Lentinan; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Polysaccharides; Sarcoma, Experimental | 1987 |
Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
Topics: Animals; Biological Products; Combined Modality Therapy; Cyclophosphamide; Hypersensitivity, Delayed; Immunotherapy; Lentinan; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Picibanil; Polysaccharides, Bacterial | 1985 |
Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dactinomycin; Doxorubicin; Glycoproteins; Growth Inhibitors; Lentinan; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mitomycin; Mitomycins; Neoplasms, Experimental; Polysaccharides; Tumor Necrosis Factor-alpha | 1985 |
[Experimental studies on growth inhibition and regression of cancer metastases].
Topics: Animals; Combined Modality Therapy; Fibrosarcoma; Humans; Lentinan; Liver Neoplasms, Experimental; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasms, Experimental; Rats | 1985 |